Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease

NCT03796975 PHASE4 COMPLETED

This is an multicenter, randomized, double-blind, parallel-controlled study to evaluated the efficacy of pioglitazone hydrochloride and metformin hydrochloride tablets on the patients with newly diagnosed type 2 diabetes mellitus combined with non-alcoholic fatty liver disease.

Details

Lead sponsor	Xijing Hospital
Phase	PHASE4
Status	COMPLETED
Enrolment	120
Start date	Thu Jun 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Nov 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Type 2 Diabetes Mellitus
• Non-alcoholic Fatty Liver Disease
• Efficacy

Interventions

• Combination of Pioglitazone and Metformin Tablets
• Metformin Hydrochloride Tablets

Countries

China